NextPlat Corp. (NASDAQ:NXPL) Short Interest Update

NextPlat Corp. (NASDAQ:NXPL) was the recipient of a significant increase in short interest in January. As of January 15th, there was short interest totaling 196,412 shares, an increase of 34.2% from the December 31st total of 146,349 shares. Currently, 1.3% of the shares of the company are short sold. Based on an average daily volume of 84,362 shares, the days-to-cover ratio is currently 2.3 days. Based on an average daily volume of 84,362 shares, the days-to-cover ratio is currently 2.3 days. Currently, 1.3% of the shares of the company are short sold.

NextPlat Stock Performance

Shares of NXPL stock traded down $0.02 on Friday, reaching $0.67. The stock had a trading volume of 25,912 shares, compared to its average volume of 56,747. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.80 and a current ratio of 3.56. NextPlat has a 1 year low of $0.43 and a 1 year high of $1.12. The stock has a market cap of $17.65 million, a P/E ratio of -2.24 and a beta of 1.15. The company has a 50 day simple moving average of $0.64 and a 200 day simple moving average of $0.72.

NextPlat (NASDAQ:NXPL) last posted its earnings results on Wednesday, November 12th. The company reported ($0.08) earnings per share for the quarter. The firm had revenue of $13.75 million during the quarter. NextPlat had a negative net margin of 14.58% and a negative return on equity of 34.22%.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of NextPlat in a research report on Monday, December 22nd. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock currently has an average rating of “Sell”.

Institutional Trading of NextPlat

An institutional investor recently bought a new position in NextPlat stock. Citadel Advisors LLC bought a new stake in shares of NextPlat Corp. (NASDAQ:NXPL) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 48,176 shares of the company’s stock, valued at approximately $40,000. Citadel Advisors LLC owned about 0.19% of NextPlat at the end of the most recent quarter. Hedge funds and other institutional investors own 1.30% of the company’s stock.

NextPlat Company Profile

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.